Table 7.
Joinpoint Analyses (1992–2008)b | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Trend 1 | Trend 2 | Trend 3 | Trend 4 | AAPCc | ||||||
Sex/Cancer Site or Typed | Years | APCe | Years | APCe | Years | APCe | Years | APCe | 1999–2008 | 2004–2008 |
Both sexes | ||||||||||
Adenocarcinoma of esophagus | 1992–1999 | 5.4f | 1999–2008 | 1.2 | 1.2 | 1.2 | ||||
(Delay-adjusted) | 1992–1999 | 5.4f | 1999–2008 | 1.3 | 1.3 | 1.3 | ||||
Colon and rectum | 1992–1995 | −2.1f | 1995–1998 | 1.7 | 1998–2008 | −2.4f | −2.4g | −2.4g | ||
(Delay-adjusted) | 1992–1995 | −2.1f | 1995–1998 | 1.7 | 1998–2008 | −2.3f | −2.3g | −2.3g | ||
Colon | 1992–1995 | −2.1f | 1995–1998 | 1.5 | 1998–2008 | −2.4f | −2.4g | −2.4g | ||
(Delay-adjusted) | 1992–1995 | −2.1f | 1995–1998 | 1.5 | 1998–2008 | −2.3f | −2.3g | −2.3g | ||
Pancreas | 1992–2000 | −0.1 | 2000–2008 | 1.1f | 0.9g | 1.1g | ||||
(Delay-adjusted) | 1992–2001 | 0.0 | 2001–2008 | 1.5f | 1.2g | 1.5g | ||||
Kidney and renal pelvis | 1992–1999 | 1.4f | 1999–2008 | 3.0f | 3.0g | 3.0g | ||||
(Delay-adjusted) | 1992–1997 | 1.1f | 1997–2005 | 2.6f | 2005–2008 | 4.4f | 3.2g | 3.9g | ||
Men | ||||||||||
Adenocarcinoma of esophagus | 1992–2008 | 2.5f | 2.5g | 2.5g | ||||||
(Delay-adjusted) | 1992–2008 | 2.6f | 2.6g | 2.6g | ||||||
Colon and rectum | 1992–1995 | −2.6f | 1995–1998 | 1.5 | 1998–2008 | −2.7f | −2.7g | −2.7g | ||
(Delay-adjusted) | 1992–1995 | −2.6f | 1995–1998 | 1.5 | 1998–2008 | −2.6f | −2.6g | −2.6g | ||
Colon | 1992–1995 | −2.9f | 1995–1998 | 1.5 | 1998–2008 | −2.8f | −2.8g | −2.8g | ||
(Delay-adjusted) | 1992–1995 | −2.9f | 1995–1998 | 1.4 | 1998–2008 | −2.7f | −2.7g | −2.7g | ||
Pancreas | 1992–2002 | 0.0 | 2002–2008 | 1.4f | 0.9g | 1.4g | ||||
(Delay-adjusted) | 1992–2002 | 0.0 | 2002–2008 | 1.8f | 1.2g | 1.8g | ||||
Kidney and renal pelvis | 1992–2008 | 2.2f | 2.2g | 2.2g | ||||||
(Delay-adjusted) | 1992–2006 | 2.0f | 2006–2008 | 6.2f | 2.9g | 4.1g | ||||
Women | ||||||||||
Adenocarcinoma of esophagus | 1992–2008 | 3.2f | 3.2g | 3.2g | ||||||
(Delay-adjusted) | 1992–2008 | 3.3f | 3.3g | 3.3g | ||||||
Colon and rectum | 1992–1995 | −1.9f | 1995–1998 | 1.9 | 1998–2008 | −2.1f | −2.1g | −2.1g | ||
(Delay-adjusted) | 1992–1995 | −1.8f | 1995–1998 | 1.9 | 1998–2008 | −2.0f | −2.0g | −2.0g | ||
Colon | 1992–2000 | −0.2 | 2000–2008 | −2.3f | −2.0g | −2.3g | ||||
(Delay-adjusted) | 1992–2000 | −0.2 | 2000–2008 | −2.2f | −1.9g | −2.2g | ||||
Pancreas | 1992–2008 | 0.5f | 0.5g | 0.5g | ||||||
(Delay-adjusted) | 1992–2000 | −0.1 | 2000–2008 | 1.4f | 1.2g | 1.4g | ||||
Kidney and renal pelvis | 1992–1998 | 1.2 | 1998–2008 | 3.1f | 3.1g | 3.1g | ||||
(Delay-adjusted) | 1992–1998 | 1.1 | 1998–2008 | 3.3f | 3.3g | 3.3g | ||||
Breast (aged ≥50 y) | 1992–1999 | 1.7f | 1999–2004 | −2.9f | 2004–2008 | 0.0 | −1.6g | 0.0 | ||
(Delay-adjusted) | 1992–1999 | 1.6f | 1999–2005 | −2.6f | 2005–2008 | 1.0 | −1.4g | 0.1 | ||
Corpus and uterus, NOS | 1992–2006 | −0.2 | 2006–2008 | 2.3 | 0.4 | 1.1 | ||||
(Delay-adjusted) | 1992–2006 | −0.2 | 2006–2008 | 2.7 | 0.5 | 1.2 |
Abbreviations: AAPC indicates average annual percent change; APC, annual percent change; NOS, not otherwise specified.
Source: SEER 13 areas covering about 14% of the US population (Connecticut, Hawaii, Iowa, Utah, and New Mexico, the Alaska Native Tumor Registry, rural Georgia and the metropolitan areas of San Francisco, Los Angeles, San Jose-Monterey, Detroit, Atlanta, and Seattle-Puget Sound).
Joinpoint analyses with up to 3 joinpoints yielding up to 4 trend segments (Trends 1–4) were based on rates per 100,000 persons and were age-adjusted to the 2000 US standard population (19 age groups: ages <1 year, 1–4 years, 5–9 years, …, 80–84 years, ≥85 years; Census publication p25-1130; US Bureau of the Census, Current Population Reports, p25-1130. Washington, DC: US Government Printing Office, 2000). For joinpoint analysis, the Joinpoint Regression Program was used (version 3.5, April 2011; Surveillance Research Program, National Cancer Institute, Bethesda, Md).
The AAPC is a weighted average of the APCs calculated by joinpoint regression.
Cancers are sorted according to International Classification of Diseases for Oncology Third Edition code. Adenocarcinoma of the esophagus is restricted to esophageal cancers with microscopically confirmed histology codes in the range from 8140 to 8575. Myelodysplastic syndromes are excluded from cancer-specific analyses.
The APC is based on rates that were age-adjusted to the 2000 US standard population (19 age groups: <1, 1–4, 5–9, …, 80–84, ≥85 years; Census publication p25-1130).
The APC is statistically significantly different from zero (2-sided t test; P <.05).
The AAPC is statistically significantly different from zero (2-sided Z test; P <.05).